Welcome to our dedicated page for iRhythm Holdings SEC filings (Ticker: IRTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
iRhythm Holdings, Inc. filings document the public-company reporting of a digital health care business centered on ambulatory cardiac monitoring. Recent Form 8-K disclosures report operating results, financial condition, guidance-related exhibits, Regulation FD materials, material agreements, executive compensation policy changes, board appointments, and changes in the independent registered public accounting firm.
Proxy materials cover director elections, board and committee structure, executive compensation, equity awards, and stockholder voting matters. The filing record also documents the completed holding-company reorganization under which iRhythm Holdings became successor registrant to iRhythm Technologies, including common-stock continuity and predecessor registration-termination records.
MCGINNIS KAREN K reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings, Inc. director Karen K. McGinnis received an equity grant of 1,573 shares of common stock in the form of restricted stock units (RSUs). The award was granted at no cash cost per share and is part of her director compensation.
Each RSU represents a contingent right to receive one share of iRhythm common stock. The RSUs vest on the earlier of one year after the grant date or the company’s next annual meeting. After this grant, McGinnis directly holds 3,608 shares of common stock.
OBOYLE KEVIN C reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings director Kevin C. O’Boyle received an equity grant of 1,573 restricted stock units. The RSUs were awarded at no cash cost and each unit represents a right to one share of iRhythm common stock. The award vests on the earlier of one year after grant or the company’s next annual meeting. Following this grant, O’Boyle directly holds 3,608 shares.
TALWALKAR ABHIJIT Y reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings, Inc. director Abhijit Y. Talwalkar received a grant of 1,573 shares in the form of restricted stock units. Each RSU represents a contingent right to receive one share of iRhythm common stock. The RSUs vest on the earlier of one year after grant or the company’s next annual meeting, bringing his direct holdings to 21,872 shares.
YOOR BRIAN B reported acquisition or exercise transactions in this Form 4 filing.
iRhythm Holdings, Inc. director Brian B. Yoor reported receiving an equity award of 1,573 shares of common stock as a grant, with no cash paid per share. After this award, he holds 7,171 shares directly. The award consists of restricted stock units, each convertible into one share of common stock, vesting on the earlier of one year after grant or the company’s next annual meeting.
iRhythm Holdings, Inc. reported results of its 2026 Annual Meeting of Stockholders held on May 27, 2026. Stockholders approved the new 2026 Equity Incentive Plan, which replaces the 2016 plan and had previously been approved by the board, and all nine director nominees were elected to serve until the 2027 annual meeting.
Stockholders also approved an amended and restated certificate of incorporation for iRhythm Technologies, Inc. to remove the pass‑through voting provision, ratified the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, and supported, on a non‑binding advisory basis, the compensation of the company’s named executive officers.
iRhythm Holdings, Inc. ownership disclosure: RTW Investments, LP and Roderick Wong report beneficial ownership of 1,668,500 shares of Common Stock, representing 5.2% of the class. The filing cites 32,316,760 Shares outstanding as of February 12, 2026. The statement is signed by Dr. Wong on May 15, 2026.
iRhythm Holdings, Inc. director Abhijit Y. Talwalkar reported option exercises and offsetting share sales under a pre-set trading plan. On May 11, 2026, he exercised 5,312 Employee Stock Options at $10.71 per share and acquired the same number of common shares.
That same day he sold an aggregate of 5,312 common shares in multiple open‑market transactions at prices ranging from about $115.61 to $120.53, resulting in no net change in his common stock holdings. After these transactions, he directly owned 25,611 common shares. All trades were executed pursuant to a Rule 10b5-1 trading plan established on May 12, 2025.
IRTC disclosed a proposed sale of 5,312 shares of Common Stock through a stock option exercise to be effected on 05/11/2026 with cash as the consideration. The filing lists $773,981.24 tied to securities sold in the past three months and attributes the transaction to an issuer-directed exercise.
iRhythm Holdings, Inc. - Sands Capital Management, LLC and Frank M. Sands filed Amendment No. 6 to a Schedule 13G/A reporting beneficial ownership of 5% or less of the issuer's common stock (CUSIP 450056106). The filing states securities are held in various client accounts and that no single client's interest exceeds 5%.
The filing cites 32,862,408 shares outstanding as of April 23, 2026 (per the issuer's Form 10-Q). Sands is identified as having ultimate voting and investment power over securities held by Sands Capital. Signatures are dated 05/08/2026.
iRhythm Holdings, Inc. Chief Technology Officer Lawrence Brian Lee reported a small share disposition linked to equity compensation. On this Form 4, he sold 1,014 shares of common stock at $120.80 per share, and held 20,154 shares afterward.
According to the footnote, these shares were sold specifically to cover tax withholding and remittance obligations arising from the vesting of Restricted Stock Units (RSUs), indicating a routine, compensation-related transaction rather than a discretionary open-market sale for portfolio reasons.